The inhibitory activity (IA) of calcium oxalate crystallization was investigated in healthy Indians and renal stone formers. A marked circadian rhythm was observed in men and women of both groups. The rhythm pattern was similar on the basis of sex; however, it was different in stone formers as compared to normals. The acrophase for crystallization of calcium oxalate was observed,respectively, at 05.43 and 05.52 h in healthy men and women, and at 09.52 and 09.23 h in male and female renal stone formers. Moreover, the acrophase of percent inhibition by IA was observed at 17.44 and 17.52 h in healthy participants and at 21.52 and 21.27 h in male and female stone formers, respectively. Therefore, the acrophase suggests a highest risk of crystallization during the morning hours and a minimum one during the evening hours. The daynight rhythmic pattern of urinary calcium, magnesium and phosphorus is discussed in relation to the rhythm of IA.

Keywords:
Circadian periodicity, Inhibitory activity, Calcium oxalate, Crystallization, Renal stone formers, Tropical conditions
This content is only available via PDF.
1993
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.